POPULAR Pharmaceutical limited
Popular Pharmaceuticals Ltd. (PPL), the pioneer manufacturer of Human Insulin in Bangladesh, is a company of Popular Group, the leading corporate house in the private sector Health Care Management of the country. PPL is manufacturing and marketing its high quality and wide variety of product range both in home and abroad.PPL has an aim to lead the market of Branded Generics in Bangladesh with a portfolio of vital molecules while at the same time, progressing for the next wave of novel products
The State of the Art manufacturing facilities of Popular Pharmaceuticals Ltd. (PPL), is located in an industrial area close to the International Airport of the capital city, Dhaka. The total land area of this site is 22,952 m2 with a covered area of 13,509 m2.The manufacturing site is built with strict compliance to WHO cGMP standards and also to meet US FDA and UK MHRA requirements.The project involved an investment of BDT 2,000 M (US$ 30 M approx.); the ever highest initial investment for a pharmaceutical plant in Bangladesh and financed by six leading Financial Institutions and Banks. Through captivating marketing strategies coupled with optimum productivity across all its activities with quality People, Plant and Product, PPL is committed to deliver top tier performance round the year. PPL is continuously investing in diversifying the ranges of products and services to complement the aura with all the major therapeutic areas.Delivering PPL’s core values through a responsible approach to business by introducing differentiated medicines that make a real contribution to the health sector of Bangladesh, PPL also aims to create enduring value for the society, and deliver a sustained financial performance that will match the best in the industry.The growing demand for new medicines is driven by increasing population and improved life expectancy as modern medicine supports an ageing population. Popular Pharmaceuticals Ltd. intends to focus its skills and resources on all major therapeutic areas that represent majority of the burden of disease profiles of Bangladesh.Popular Pharmaceuticals Ltd. is also committed to delivering new, medically important and commercially successful products to the market every year. Along with its commitment to competitiveness and high performance, PPL will continue to be led by its core values to achieve sustainable success.Efficient pharmaceutical business requires transparent, quality assured processes which are acceptable to regulatory authorities worldwide in addition to the use of complementary new technologies. PPL is committed to the best use of available technology and expertise of the time and thereby ensuring continuous improvements with regards to effectiveness and efficiency.
Popular Pharmaceuticals Ltd. (PPL), the pioneer manufacturer of Human Insulin in Bangladesh, is a company of Popular Group, the leading corporate house in the private sector Health Care Management of the country. PPL is manufacturing and marketing its high quality and wide variety of product range both in home and abroad.PPL has an aim to lead the market of Branded Generics in Bangladesh with a portfolio of vital molecules while at the same time, progressing for the next wave of novel products
The State of the Art manufacturing facilities of Popular Pharmaceuticals Ltd. (PPL), is located in an industrial area close to the International Airport of the capital city, Dhaka. The total land area of this site is 22,952 m2 with a covered area of 13,509 m2.The manufacturing site is built with strict compliance to WHO cGMP standards and also to meet US FDA and UK MHRA requirements.The project involved an investment of BDT 2,000 M (US$ 30 M approx.); the ever highest initial investment for a pharmaceutical plant in Bangladesh and financed by six leading Financial Institutions and Banks. Through captivating marketing strategies coupled with optimum productivity across all its activities with quality People, Plant and Product, PPL is committed to deliver top tier performance round the year. PPL is continuously investing in diversifying the ranges of products and services to complement the aura with all the major therapeutic areas.Delivering PPL’s core values through a responsible approach to business by introducing differentiated medicines that make a real contribution to the health sector of Bangladesh, PPL also aims to create enduring value for the society, and deliver a sustained financial performance that will match the best in the industry.The growing demand for new medicines is driven by increasing population and improved life expectancy as modern medicine supports an ageing population. Popular Pharmaceuticals Ltd. intends to focus its skills and resources on all major therapeutic areas that represent majority of the burden of disease profiles of Bangladesh.Popular Pharmaceuticals Ltd. is also committed to delivering new, medically important and commercially successful products to the market every year. Along with its commitment to competitiveness and high performance, PPL will continue to be led by its core values to achieve sustainable success.Efficient pharmaceutical business requires transparent, quality assured processes which are acceptable to regulatory authorities worldwide in addition to the use of complementary new technologies. PPL is committed to the best use of available technology and expertise of the time and thereby ensuring continuous improvements with regards to effectiveness and efficiency.
No comments:
Post a Comment